Robert Lakin

Robert Lakin

InvestorPlace Contributor

A journalist — both writer and editor — Robert has covered markets and economies for more than 20 years. His previous gigs include Bloomberg News, where he was emerging markets editor in Tel Aviv, McKinsey & Co. and McDonald & Company Investments, where he was equities research editor.

His deep experience includes covering startups, emerging markets, financial services, and capital markets.

He writes a Substack newsletter, TLV Strategist, which covers the Israel business scene.

Recent Articles

Invest in TruckBux for Major Disruption in the Food Truck Business

By Robert Lakin, InvestorPlace Contributor

A mobile app is set to disrupt the food truck business, especially amid the pandemic. Here's how you can invest in TruckBux to profit.

Earnings Season Kicks Off Amid Pandemic as Companies Pull Guidance

By Robert Lakin, InvestorPlace Contributor

Corporate earnings among companies in the S&P 500 are expected to have fallen nearly 45% in Q2 YoY.

Vanguard, BlackRock Gain Most New ETF Business, JPMorgan on the Rise

By Robert Lakin, InvestorPlace Contributor

Global ETF assets stood at $6.3 trillion at the end of June, down 1.4% this year.

Invest in Heal to Benefit From the Disruption in Primary Care

By Robert Lakin, InvestorPlace Contributor

Healthcare startup Heal combines in-home doctors' visits, big data and innovative telemedicine. Here's how you can invest in Heal right now.

VasoGnosis Stock Is a Seed-Stage Investment in New Medical Technology

By Robert Lakin, InvestorPlace Contributor

Medical technology is revolutionizing healthcare, and one startup in the space is looking to cash in. Here's why VasoGnosis stock stands out.

Klarna Stock Benefits from Growing Trends in Retail and Fintech

By Robert Lakin, InvestorPlace Contributor

Regardless of whether you invest in Klarna stock in the near future, keep the buy now, pay later fintech in your sights. Here's why.

Hexo CFO Calls it Quits After 5 Months on the Job

By Robert Lakin, InvestorPlace Contributor

The departure comes 10 months after the pot producer said in a release that a CFO transition plan was in place for Hexo.

Investors Need to Change Their Perspective on Chinese Stocks

By Robert Lakin, InvestorPlace Contributor

China's rebounding domestic economy has created incredible opportunities investors. Based on the holdings of GAM China Evolution Fund, here are some Chinese stocks from the consumer, financial and healthcare sectors, including several less-familiar names.

Teva Pharmaceutical Industries Ltd ADR (TEVA) Names Kare Schultz As CEO

By Robert Lakin, InvestorPlace Contributor

Teva ended its leadership uncertainty with the selection of long-time pharma exec Kåre Schultz as CEO, TEVA stock is up this morning.

Blue Apron IPO: The Meal Delivery Service Files to Go Public

By Robert Lakin, InvestorPlace Contributor

Meal-kit provider Blue Apron Holdings, Inc. filed to go public after growing sales to $800 million last year.

Load More